Investigations

GRABAR LAW OFFICE INVESTIGATES CLAIMS FOR SHAREHOLDERS OF HIMS & HERS, INC. (NYSE: HIMS)

Grabar Law Office is investigating claims on behalf of shareholders of Hims & Hers, Inc. (NYSE: HIMS). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

Hims & Hers Health, Inc. is a U.S.-based telehealth company that connects users with licensed healthcare professionals who offer virtual consultations and prescribe medications tailored to a range of health and wellness goals, including hair regrowth, sexual health, and weight loss.

In May 2024, the Company began providing access to compounded injectable semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1), used for weight loss.

On April 29, 2025, Hims issued a press release which announced a long-term collaboration with Novo Nordisk, starting with the immediate sale of “a bundled offering of Novo Nordisk’s FDA-approved Wegovy® on the Hims & Hers platform.”

A recently filed securities fraud class action complaint alleges that Hims & Hers, Inc. (NYSE: HIMS), via certain of its officers, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Hims was engaged in the “deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk;” (2) that, as a result, there was a substantial risk that the Company’s collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT YOU CAN DO NOW: If you purchased Hims & Hers, Inc. (NYSE: HIMS) shares prior to April 29, 2025 and still hold shares today, you are encouraged to contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. If, alternatively, you purchased your shares between April 29, 2025 and June 22, 2025, you can participate in the class action.

Attorney Advertising Disclaimer

Join This Action
Name*
First Last
Email Address*
Address*
Street Address City State / Province / Region ZIP / Postal Code
Phone*
Stock Name or Ticker
Number of Shares Purchased
Date(s) Shares Purchased
Purchase Price Per Share
Number of Shares Sold
Date(s) Shares Sold
Sale Price Per Share
Comments
Alternatively, you may upload your transactions using the upload button below or email them to jgrabar@grabarlaw.com. *
File
Drop files here or

Max. file size: 100 MB.
Consent*
By signing and clicking the Submit button below, I hereby execute the Retention Agreement and, upon execution of the Retention Agreement by Grabar Law Office, retain Grabar Law Office to make a demand and bring any ensuing lawsuit on my behalf pursuant to the terms set forth in the Retention Agreement, which is incorporated herein by reference.*
Please sign below using your mouse or touch-pad.*
Signed pursuant to California Civil Code Section 1633.1, et seq. and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.
Date of signing: *
Date of signing:*
MM slash DD slash YYYY
Name
This field is for validation purposes and should be left unchanged.

Investigations

GRABAR LAW OFFICE INVESTIGATES CLAIMS FOR SHAREHOLDERS OF HIMS & HERS, INC. (NYSE: HIMS)

Join This Action